The new EAS consensus documents represent a major advance in the prevention and treatment of lipid metabolism disorders

At the May congress of the European Atherosclerosis Society (EAS) in Athens, two significant consensus documents were presented, to which Tomáš Freiberger of the Department of Clinical Immunology and Allergology and the Center for Cardiovascular and Transplant Surgery in Brno contributed as an author. Both documents provide important updates in the field of prevention and treatment of lipid metabolism disorders and are already generating significant attention from both the professional community and the media.

19 Jun 2026

No description

The first document focuses on the care of familial hypercholesterolemia (FH) in children and, after more than a decade, introduces significant changes in the diagnosis, genetics, and treatment of this serious hereditary disease. It redefines diagnostic criteria, recommends initiating treatment at an earlier age, and sets stricter LDL cholesterol target levels, while also presenting new therapeutic options.

The second consensus document addresses the standardization and organization of specialized centers for the treatment of severe dyslipidemias. For the first time, it introduces a categorization system based on levels of care, taking into account the varying conditions of healthcare systems in different countries.

Both documents represent significant progress in the field of preventive cardiology. They emphasize the key role of early diagnosis and targeted treatment in the prevention of serious cardiovascular diseases.

Details on familial hypercholesterolemia and the organization of lipid centers are also available on the website of the European Atherosclerosis Society:

  • https://eas-society.org/publications/familial-hypercholesterolaemia-in-children-and-adolescents/
  • https://eas-society.org/collaborations/lcn/

More articles

All articles

You are running an old browser version. We recommend updating your browser to its latest version.

More info